Press release
Bacterial conjunctivitis market: Driven by increase incidence of conjunctivitis patients across the globe by 2015 - 2021
Conjunctivitis is a communicable disease. It is also known as pink eye in the United States and madras eye in India. Conjunctivitis is an inflammation of conjunctiva. Conjunctivitis caused by bacteria, viruses and allergens. It is highly contagious diseases, spread easily through direct contact of any object like towel, napkin or by coughing and sneezing. Bacterial conjunctivitis caused mainly by both gram positive bacteria and gram negative bacteria. Common bacteria responsible for conjunctivitis are taphylococcus aureus, Pseudomonas, Serratia marcescens, Haemophilus influenza etc.Request Sample Report: http://www.zionmarketresearch.com/sample/bacterial-conjunctivitis-market
Symptoms of bacterial conjunctivitis are reddening of eyes, excess tears, thick yellow discharge, itching, burning sensation, blurred vision and increase sensitivity towards the light. Treatment includes using antibiotics both systemic and topical. Sometime Povidone-iodine 1.25% ophthalmic solution is also used in African countries like utopia, Uganda as an alternative of antibiotic due to its less cost.
Bacterial conjunctivitis market is driven by increase incidence of conjunctivitis patients across the globe. Exact epidemiology of this disease is difficult to estimate due to its high incidence and low prevalence. Moreover, continuous increasing incidences of bacterial conjunctivitis are responsible for market growth, bacterial conjunctivitis accounts for more than 50% of the cases. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies are expected to open growth avenues for the market over the years.
The report covers forecast and analysis of the bacterial conjunctivitis drug market on a regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the bacterial conjunctivitis drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein product & regional segments are benchmarked based on their market size, growth rate, and general attractiveness.
Do Inquiry before buying: http://www.zionmarketresearch.com/inquiry/bacterial-conjunctivitis-market
The report provides detailed segmentation of the bacterial conjunctivitis drug market based on product segment and regional segment. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Demand has been analyzed and forecast based on the current trends for the period of six years. North America was the leading segment of bacterial conjunctivitis drug market followed by Europe in 2015. The bacterial conjunctivitis drug market is expected to witness the good growth in the Asia-Pacific region, especially in India and China in the coming years due to the rising population and pandemic nature of conjunctivitis diseases.
Key players included in the report are Allergan, Inc., Merck, Pfizer, Inc., Novartis and others.
This report segments the global bacterial conjunctivitis markets follows:
Bacterial Conjunctivitis Market: Product Segment Analysis
Fluoroquinolones
Macroloides
Aminoglycosides
Others
Browse detail report at: http://www.zionmarketresearch.com/report/bacterial-conjunctivitis-market
Bacterial Conjunctivitis Market: Regional Segment Analysis
North America
Europe
Asia Pacific
Latin America
The Middle East & Africa
About Us:
Zion Market Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. Zion Market Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading industry and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
Contact Us:
Zion Market Research
4283, Express Lane,
Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial conjunctivitis market: Driven by increase incidence of conjunctivitis patients across the globe by 2015 - 2021 here
News-ID: 359518 • Views: …
More Releases from zion market research

Global Adaptive Stroller Market Size to Reach ~USD 852.31 Million by 2034, Growi …
The global adaptive stroller market-specialized strollers designed for children with disabilities or special mobility needs-was valued at approximately USD 325.63 million in 2024 and is projected to reach around USD 852.31 million by 2034, expanding at a compound annual growth rate (CAGR) of about 10.10% from 2025 to 2034. Growth is fueled by increasing awareness of inclusive mobility solutions, rising incidence of pediatric disabilities, and the adoption of ergonomic and…

Global D-Xylose Test Market Size to Surpass USD 723 Million by 2034, Expanding a …
The global D-xylose test market, a key diagnostic tool for evaluating intestinal absorption and malabsorption disorders, was valued at approximately USD 478.45 million in 2024 and is projected to reach about USD 723.21 million by 2034, growing at a compound annual growth rate (CAGR) of 5.30% from 2025 to 2034. Rising awareness of malabsorption syndromes, improved gastrointestinal (GI) diagnostics, and the prevalence of celiac disease and chronic pancreatitis are fueling…

Global Sacral Neuromodulation Market to Exceed USD 5.08 Billion by 2034, Acceler …
The global sacral neuromodulation (SNM) market-driven by rising prevalence of overactive bladder, urinary incontinence, and fecal incontinence-was valued at USD 1.76 billion in 2024 and is projected to grow to USD 5.08 billion by 2034, registering a strong compound annual growth rate (CAGR) of about 11.20% during 2025-2034. Advancements in minimally invasive implant systems, favorable reimbursement, and increasing awareness of neurostimulation therapies are fueling adoption worldwide.
Access key findings and insights…

Global Demi-Fine Jewelry for Women Sales Market to Reach USD 3.91 Billion by 203 …
The global demi-fine jewelry for women sales market was valued at USD 2.52 billion in 2024 and is projected to grow to USD 3.91 billion by 2034, expanding at a CAGR of 4.48% between 2025 and 2034.
Demi-fine jewelry has emerged as a bridge between luxury fine jewelry and affordable fashion accessories. Crafted from high-quality materials such as sterling silver, vermeil, and semi-precious stones, it offers women style, durability, and affordability.…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…